- Home
- SSII
as 05-30-2025 4:00pm EST
Stocks
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India.
| Founded: | N/A | Country: | India |
| Employees: | N/A | City: | FORT LAUDERDALE |
| Market Cap: | 1.9B | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 91.3K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.09 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.32 - $22.42 | Next Earning Date: | 05-14-2025 |
| Revenue: | $22,132,445 | Revenue Growth: | 176.60% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest SS Innovations International Inc. Common Stock News
SSII Breaking Stock News: Dive into SSII Ticker-Specific Updates for Smart Investing
GlobeNewswire
4 days ago
SS Innovations Surpasses Milestone of 4,000 Robotic Surgeries Successfully Performed with the SSi Mantra Surgical Robotic System
GlobeNewswire
16 days ago
SS Innovations Reports First Quarter 2025 Financial Results
GlobeNewswire
23 days ago
SS Innovations to Submit De Novo Application to the FDA for the SSi Mantra 3 Surgical Robotic System for Multiple Indications
GlobeNewswire
a month ago
SS Innovations Reiterates Guidance for First Quarter 2025 and Provides Commentary on Second Quarter 2025 Order Trends
GlobeNewswire
a month ago
SS Innovations Announces Chief Financial Officer Transition
Compare SSII vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SSII SS Innovations International Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.